Filter
Top Products
Stratos LV/LV-T Technical Manual 25
Table 2: Atrial Fibrillation Demographics at Enrollment
Characteristic Group 1 Group 2 Group 3 P-value*
Classification of
Atrial Fibrillation
Persistent AF
Permanent AF
N=42
10 (23.8%)
32 (76.2%)
N=50
17 (34%)
33 (66%)
N=24
6 (25%)
18 (75%)
0.537
Classification of
Symptoms Related
to AF
Palpitations
Chest Pain
Dyspnea or shortness
of breath
Fatigue
Lightheadedness or
syncope
Other
N=42
32 (76.2%)
6 (14.3%)
36 (85.7%)
34 (81.0%)
17 (40.5%)
9 (21.4%)
N=49
34 (69.4%)
7 (14.3%)
40 (81.6%)
45 (91.8%)
13 (26.5%)
11 (22.4%)
N=25
14 (56.0%)
3 (12.0%)
19 (76.0%)
18 (72.0%)
9 (36.0%)
10 (40.0%)
0.236
1.000
0.568
0.149
0.329
0.205
Previous AF
Ablation
No
Yes
N=42
37 (88.1%)
5 (11.9%)
N=50
47 (94.0%)
3 (6.0%)
N=25
21 (84.0%)
4 (16.0%)
0.354
Past Medications
for Rate or Rhythm
Control
Amiodarone
Digoxin
Diltiazem
Disopyramide
Dofetilide
Flecanide
Ibutilide
Procainamide
Propafenone
Sotolol
Verapamil
Metoprolol
Propranolol
Other Beta-Blockers
Other Medications
N=41
12 (29.3%)
17 (41.5%)
17 (41.5%)
0 (0.0%)
4 (9.8%)
5 (12.2%)
0 (0.0%)
0 (0.0%)
2 (4.9%)
9 (22.0%)
5 (12.2%)
19 (46.3%)
0 (0.0%)
7 (17.1%)
5 (12.2%)
N=48
10 (20.8%)
22 (45.8%)
23 (47.9%)
3 (6.3%)
3 (6.3%)
5 (10.4%)
0 (0.0%)
2 (4.2%)
4 (8.3%)
10 (20.8%)
8 (16.7%)
28 (58.3%)
0 (0.0%)
15 (31.3%)
5 (10.4%)
N=24
10 (41.7%)
13 (54.2%)
12 (50.0%)
0 (0.0%)
2 (8.3%)
1 (4.2%)
1 (4.2%)
0 (0.0%)
0 (0.0%)
2 (8.3%)
3 (12.5%)
10(41.7%)
1 (4.2%)
4 (16.7%)
1 (4.2%)
0.192
0.683
0.804
0.228
0.895
0.656
0.215
0.506
0.423
0.389
0.829
0.382
0.215
0.248
0.656